Healthcare News and Research

Latest Healthcare News and Research

NIH-sponsored Phase 1 clinical trial evaluates novel investigational West Nile virus vaccine

A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored Phase 1, first-in-human, clinical trial at Duke University. Although several early-stage West Nile virus vaccine clinical trials have been completed to date, no human vaccine has been approved for commercial use.

7 May 2015

Smartphone checks blood for parasitic disease

New Smartphone technology has been developed that can detect and count wriggling parasitic worms in a drop of blood...

7 May 2015

Kaiser Permanente, Intermountain Healthcare to participate in U.S. News Hospital Outcome Data Disclosure Program

U.S. News & World Report, publisher of Best Hospitals and Best Children's Hospitals, today announced that Kaiser Permanente and Intermountain Healthcare will participate in the U.S. News Hospital Outcome Data Disclosure Program, a new data-collection initiative designed to evaluate hospitals more completely and give patients better information about the hospitals in their communities.

7 May 2015

Egalet announces business highlights, financial results for first quarter 2015

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today reported business highlights and financial results for the three months ended March 31, 2015.

7 May 2015

DaVita HealthCare Partners recognizes May as Employee Health Month

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, recognizes the month of May as Employee Health Month. The health of teammates is vital in helping to ensure they can provide the best quality of care for DaVita HealthCare Partners' patients.

7 May 2015

BD reports revenues of $2.051 billion for second fiscal quarter 2015

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly revenues of $2.051 billion for the second fiscal quarter ended March 31, 2015, representing a decrease of 1.0 percent from the prior-year period, or an increase of 4.9 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 7 May 2015

Wearable cognitive assessment devices a step closer as Cambridge Cognition file new patents

The combination of bio-behavioural measures and results from touch-screen cognitive tests would be used to build up a picture of a person’s mental function...

7 May 2015

Global haemophilia therapeutics market estimated to reach $13.43 billion in 2019

Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are likely to command a premium price and fuel growth in developed markets, while heightened access to treatment and larger patient volumes due to more funding for critical care are anticipated to contribute to demand in emerging markets.

7 May 2015

DePuy Synthes CMF introduces SYNTHECEL Dura Repair for use in neurosurgery

DePuy Synthes CMF today announced the launch of SYNTHECEL Dura Repair, the first commercially available biosynthesized dural replacement derived from cellulose for use in neurosurgery. DePuy Synthes CMF is a part of the DePuy Synthes Companies of Johnson & Johnson.

7 May 2015

Memorial Sloan Kettering introduces innovative and personalized online platform

Memorial Sloan Kettering Cancer Center introduced a new, consumer-friendly web presence for www.mskcc.org (Memorial Sloan Kettering Cancer Center) and www.sloankettering.edu (Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center), featuring an innovative platform and on-demand navigation for patients, caregivers, researchers, healthcare professionals, and graduate students, among other core audiences.

7 May 2015

Penn State College of Medicine awarded PCORI grant to study exercise program for older adults

Penn State College of Medicine was awarded nearly $14 million in funding from the Patient-Centered Outcomes Research Institute to study the effectiveness of a program integrating strength training, balance exercises and walking for older adults who have had a fall-related fracture.

7 May 2015

New app may help parents save lives of premature babies

A new app launched by The University of Nottingham is offering parents of newborn infants the chance to play a crucial role in research that could save the lives of premature babies in the developing world.

7 May 2015

Researchers report new primary care model to address trauma

Recognizing that patients' experiences of childhood and adult trauma are common and have a direct impact on their health, UCSF clinical researchers and Positive Women's Network-USA have developed and are reporting a new primary care model.

7 May 2015

Medilink UK Awards - The Winners 2015

The best of the UK's Life Sciences and Healthcare Technology sector have been honoured at the 2015 Medilink UK Awards.

6 May 2015

Rasmussen College announces launch of three new Health Sciences degree programs

Rasmussen College, a regionally accredited private college and Public Benefit Corporation, today announced the launch of three new Health Sciences programs: a Health and Wellness Bachelor's degree-completion program, Medical Administrative Assistant Certificate and Pharmacy Technician Certificate.

6 May 2015

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).

6 May 2015

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

Cipher Pharmaceuticals Inc. today announced it has strengthened its Canadian dermatology portfolio by acquiring the Canadian rights to Vaniqa and Actikerall from Almirall S. A., a Spanish pharmaceutical company. Both products have been approved by Health Canada.

6 May 2015

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay) and rilpivirine (Edurant) as maintenance therapy for adult patients with HIV.

6 May 2015

Acacia Pharma reports positive results from APD403 Phase 2 study in CINV

Acacia Pharma Ltd, a specialty pharmaceutical company developing supportive care products for post-surgical and cancer patients in the US and international markets, announces positive results from its Phase 2 study of APD403 in the prevention of chemotherapy-induced nausea & vomiting (CINV).

6 May 2015

Exalenz Bioscience investigates clinical utility of BreathID test to diagnose NASH

Exalenz Bioscience, a leader in developing and marketing of non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced the initiation of a clinical study evaluating the potential of its BreathID test to diagnose nonalcoholic steatohepatitis (NASH).

6 May 2015

Healthcare News and Research

Latest Healthcare News and Research

NIH-sponsored Phase 1 clinical trial evaluates novel investigational West Nile virus vaccine

Smartphone checks blood for parasitic disease

Kaiser Permanente, Intermountain Healthcare to participate in U.S. News Hospital Outcome Data Disclosure Program

Egalet announces business highlights, financial results for first quarter 2015

DaVita HealthCare Partners recognizes May as Employee Health Month

BD reports revenues of $2.051 billion for second fiscal quarter 2015

Wearable cognitive assessment devices a step closer as Cambridge Cognition file new patents

Global haemophilia therapeutics market estimated to reach $13.43 billion in 2019

DePuy Synthes CMF introduces SYNTHECEL Dura Repair for use in neurosurgery

Memorial Sloan Kettering introduces innovative and personalized online platform

Penn State College of Medicine awarded PCORI grant to study exercise program for older adults

New app may help parents save lives of premature babies

Researchers report new primary care model to address trauma

Medilink UK Awards - The Winners 2015

Rasmussen College announces launch of three new Health Sciences degree programs

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

Acacia Pharma reports positive results from APD403 Phase 2 study in CINV

Exalenz Bioscience investigates clinical utility of BreathID test to diagnose NASH

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in